Showing results 4 to 8 of 8
< previous
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy Proceeding/Conference:Journal of Hepatology | 2007 | 154 | ||
A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 results Proceeding/Conference:Hepatology | 2006 | 126 | ||
A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Results of the Primary Week 24 Analysis Proceeding/Conference:Gastroenterology | 2006 | 139 | ||
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B Journal:Hepatology International | 2012 | 166 | ||
Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial Journal:Annals of Internal Medicine | 2007 | 112 |